loading
前日終値:
$3.76
開ける:
$3.72
24時間の取引高:
1.23M
Relative Volume:
1.23
時価総額:
$228.23M
収益:
-
当期純損益:
$-96.66M
株価収益率:
-1.5535
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
-20.29%
1か月 パフォーマンス:
-23.57%
6か月 パフォーマンス:
-72.85%
1年 パフォーマンス:
-69.33%
1日の値動き範囲:
Value
$3.28
$3.835
1週間の範囲:
Value
$3.28
$4.255
52週間の値動き範囲:
Value
$3.28
$16.62

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
名前
Olema Pharmaceuticals Inc
Name
セクター
Healthcare (1165)
Name
電話
(415) 651-3316
Name
住所
780 BRANNAN STREET, SAN FRANCISCO
Name
職員
88
Name
Twitter
Name
次回の収益日
2025-03-18
Name
最新のSEC提出書
Name
OLMA's Discussions on Twitter

OLMA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
OLMA
Olema Pharmaceuticals Inc
3.34 228.23M 0 -96.66M -83.73M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-04-02 開始されました Goldman Buy
2024-01-30 開始されました Citigroup Buy
2023-07-21 開始されました Oppenheimer Outperform
2023-05-05 開始されました CapitalOne Overweight
2023-02-22 開始されました Credit Suisse Outperform
2022-07-06 再開されました Canaccord Genuity Buy
2022-06-09 アップグレード H.C. Wainwright Neutral → Buy
2022-02-28 開始されました H.C. Wainwright Neutral
2021-12-07 再開されました Cowen Outperform
2020-12-14 開始されました Canaccord Genuity Buy
2020-12-14 開始されました Cowen Outperform
2020-12-14 開始されました JP Morgan Overweight
2020-12-14 開始されました Jefferies Buy
すべてを表示

Olema Pharmaceuticals Inc (OLMA) 最新ニュース

pulisher
Apr 01, 2025

Top Premarket Decliners - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

87,476 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Acquired by HighTower Advisors LLC - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat

Mar 31, 2025
pulisher
Mar 29, 2025

Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Mar 29, 2025
pulisher
Mar 27, 2025

Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire

Mar 26, 2025
pulisher
Mar 25, 2025

Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

HC Wainwright Has Positive Forecast for OLMA Q1 Earnings - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat

Mar 23, 2025
pulisher
Mar 22, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat

Mar 22, 2025
pulisher
Mar 22, 2025

Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Olema Pharmaceuticals Inc (OLMA) Shares Rise Despite Market Challenges - The News Heater

Mar 21, 2025
pulisher
Mar 21, 2025

Olema Oncology Reports 2024 Financial and Clinical Progress - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Outperform” Rating from Oppenheimer - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

HC Wainwright Reiterates “Buy” Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

What is HC Wainwright’s Forecast for OLMA FY2029 Earnings? - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.94 By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.94 - Investing.com India

Mar 20, 2025
pulisher
Mar 19, 2025

Olema Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025
pulisher
Mar 18, 2025

Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Olema Oncology price target lowered to $25 from $30 at Oppenheimer - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Olema Pharmaceuticals Q4 Net Loss Widens -March 18, 2025 at 04:37 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Olema Pharmaceuticals Inc Reports Q4 2024 EPS of -$0.63 and Net - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

Olema Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

Olema Pharmaceuticals Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 17, 2025
pulisher
Mar 16, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Receives Buy Rating from HC Wainwright - MarketBeat

Mar 16, 2025
pulisher
Mar 14, 2025

Olema Pharmaceuticals’ (OLMA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 14, 2025
pulisher
Mar 11, 2025

Olema Pharmaceuticals stock hits 52-week low at $4.05 - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Olema Pharmaceuticals stock hits 52-week low at $4.05 By Investing.com - Investing.com UK

Mar 11, 2025
pulisher
Mar 10, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Given Buy Rating at HC Wainwright - MarketBeat

Mar 10, 2025

Olema Pharmaceuticals Inc (OLMA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):